
E115: Benralizumab for EGPA - the MANDARA Study
10/28/2024
0:00
9:52
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
More episodes from "The Evidence Based Rheumatology Podcast"
Don't miss an episode of “The Evidence Based Rheumatology Podcast” and subscribe to it in the GetPodcast app.